Yuxiao Song
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The administration sequences of immune checkpoint inhibitors and chemotherapy cause discrete efficacy when treating non-small cell lung cancer: a retrospective study.
Journal: Frontiers in immunology
Published: February 19, 2025
NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: August 11, 2024
Immune-related toxic epidermal necrolysis affecting trachea mucosal epithelium: a case report and literature review.
Journal: Frontiers in pharmacology
Published: June 24, 2024
Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study.
Journal: Journal of thoracic disease
Published: April 09, 2024
Complement C1q induces the M2-polarization of tumor-associated macrophages in lung adenocarcinoma.
Journal: Genes & diseases
Published: December 28, 2022
What is the optimal duration of immune checkpoint inhibitors in malignant tumors?
Journal: Frontiers in immunology
Published: July 01, 2022
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.
Journal: Frontiers in molecular biosciences
Published: May 18, 2020
Clinical characteristics of 82 cases of death from COVID-19.
Journal: PloS one
Published: March 20, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026